Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity

Clinical and translational science, 2022-11, Vol.15 (11), p.2685-2696 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. ;2022 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. ;COPYRIGHT 2022 John Wiley & Sons, Inc. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;ISSN: 1752-8054 ;ISSN: 1752-8062 ;EISSN: 1752-8062 ;DOI: 10.1111/cts.13394 ;PMID: 36037309

Full text available